Jakob Hohenberger ^Leaders

Jakob Hohenberger is a co-founder and serves as the CFO/COO of Celeris Therapeutics, an AI-first drug discovery company focusing on proximity-inducing compounds for diseases with high unmet medical needs. His role encompasses financial oversight and operational management, critical in streamlining the development of PIC degraders and leveraging the Celeris One platform for drug discovery.